R&D In Metabolomics to Aid in Growth of Q-TOF Mass Spectrometer Market


Mass spectrometry is often used for the measurement of analytical data and is also widely applied in scientific research. It is used to study many physical and chemical processes including the absorption of infrared radiation, superhighway functions, and photoelectric effect and is also applied in astronomy, nuclear medicine, and physics. The method is particularly useful for the measurement of relative ratios of elements in a sample and is widely used in crime investigation and forensic analysis.

Increasing demand for Q-TOF mass spectrometry in the pharmaceutical sector is expected to propel growth of the Q-TOF mass spectrometer market. Quadrupole Time-of-flight (Q-TOF) Mass Spectrometry helps in making various medicines, in detection of drugs and in different tests of body fluids. It can also enhance control of blending, granulation, drying and coating. In the pharmaceutical industry, spectrometry helps in the analysis of metal and metalloids in drug products and can also be used to work out the structure of a molecule. Such high demand leads to development and launch of new products. For instance, in June 2018, Shimadzu Corporation launched (liquid chromatography–mass spectrometry) LCMS-9030, a Q-TOF LCMS-9030 system designed to deliver high-resolution, accurate-mass detection.

Moreover, R&D in metabolomics is also expected to aid in growth of the Q-TOF mass spectrometer market. For instance, in June 2021, Washington University in St. Louis collaborated with Agilent Technologies Inc. and the biopharmaceutical company Merck to expand research in the field of metabolomics, the comprehensive study of small molecules within a biological system. Earlier in January 2021, Agilent Technologies Inc. released MassHunter Workstation Plus 11.0, MassHunter Networked Workstation 11.0, and MassHunter BioConfirm, a group of enhanced mass spectrometry and automation software solutions to support regulatory compliance guidelines. Launch of such solutions is also expected to aid in growth of the Q-TOF mass spectrometer market.

Structures for Lossless Ion Manipulation (SLIM) mass spectrometry uses moving electric fields (so-called traveling waves) to rapidly transport ions in a lossless fashion so that they can be separated. MOBILion Systems, Inc., a provider of disease diagnosis and treatment solutions, partnered with Agilent Technologies Inc. to integrate SLIM with Agilent’s Q-TOF mass spectrometry platform as the company’s first commercial product offering, to be fully commercialized in 2021. Such developments are expected to aid in growth of the Q-TOF mass spectrometer market.

Comments

Post a Comment

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Image
Dysfunction of any of these three glands can result in Meibomian gland dysfunction. A primary cause for this condition is not really the disease itself but rather the abnormal overproduction of sebum (the secreted liquid of glands). This is normally controlled by the hypothalamus-pituitary gland system which inhibits the secretion of oil. Rapidly increases the prevalence of meibomian gland dysfunction remains one of the critical factors aiding the development of the market. In fact, as per the Fellow of American College of Surgeons, meibomian gland disease, is one of the most common causes of dry eyes and around 50-70% of the elderly population has some degree of dry eye. Besides, as per the American Optometric Association’s study in 2017, over 16 million people in the U.S. were suffering from dry eye disease. Such factors can indeed stimulate growth of the U.S. meibomian gland dysfunction market. When it comes to the drug type, Cyclosporine segment seems to be exhibiting positive trac...
Read more

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Image
  North America is expected to hold the major share in the global erectile dysfunction devices market and this is attributed to the continuous innovation in the device by key players in the region. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED. Also, in August 2019, Ohio, U.S.-based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization The growing prevalence of cardiovascular or diabetes disease among men undergoing such treatment are at higher risk of developing erectile dysfunction. This is driving the growth of the  erectile dysfunction devices market . Vacuum pumps, also known as Vacuum Erection devices (VED) are gaining huge demand around the globe. According to t...
Read more

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027

Image
The expansion of direct bundle to-broiler pastry shop items have pushed the market for bakeable trays. While these items have been around for some time, the rise of new sorts of bakeable trays features the market's development as of late. Contrasted with the conventional preparing trays which are comprised of metal, the bakeable trays are produced using a ridged paper card board that is both warmth safe and water confirmation. Such trays are made to withstand temperatures up to 220°C. These bakeable or ovenable trays are offered in various sizes and shapes. Bakeable trays can even be tweaked for various end use applications. One of the differentiating highlights of bakeable trays is that they are made of bio-degradable substance and are recyclable. These are likewise endorsed by different food organizations for direct food contact making it more secure to buyer straightforwardly from them. The worldwide  bakeable trays market  is required to arrive at US$ 1,943.8 million by 20...
Read more